Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 9Recruiting 8Active not recruiting 4Unknown 3Withdrawn 2Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Thoracic 8Genitourinary 6CNS 3Breast 3Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Neoplasms, Second Primary 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Standard of Care 4Radiotherapy 4Oxaliplatin 4tislelizumab 3anlotinib 2Radiation 2Paclitaxel 2Capecitabine 2130-nm albumin-bound paclitaxel 2vedolizumab 1trastuzumab deruxtecan 1trametinib 1toripalimab 1surufatinib 1pembrolizumab 1ivosidenib 1disitamab vedotin 1coenzyme Q10 1cemiplimab 1blinatumomab 1Whole Genome Sequencing 1Ursodeoxycholic Acid 1Ultrasonography 1Tretinoin 1Thymopentin 1Surgical Procedures, Operative 1Sequence Analysis, RNA 1Respiratory Rate 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Radiosurgery × Tumor-Agnostic × Clear all
NCT05578274 2024-12-10

Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy

Soonchunhyang University Hospital

Phase NA Not yet recruiting
186 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡